Back to School: How biopharma can reboot drug development. Access exclusive analysis here

CV Therapeutics, Quintiles sales and marketing update

The companies amended a 1999 deal for QTRN's Innovex subsidiary (Parsippany, N.J.) to provide a sales force and fund

Read the full 191 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE